BR112015015493A8 - veterinary pharmaceutical composition and use of a veterinary pharmaceutical composition - Google Patents

veterinary pharmaceutical composition and use of a veterinary pharmaceutical composition Download PDF

Info

Publication number
BR112015015493A8
BR112015015493A8 BR112015015493A BR112015015493A BR112015015493A8 BR 112015015493 A8 BR112015015493 A8 BR 112015015493A8 BR 112015015493 A BR112015015493 A BR 112015015493A BR 112015015493 A BR112015015493 A BR 112015015493A BR 112015015493 A8 BR112015015493 A8 BR 112015015493A8
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
veterinary pharmaceutical
phenylpyrazole
permethrin
topical veterinary
Prior art date
Application number
BR112015015493A
Other languages
Portuguese (pt)
Other versions
BR112015015493B1 (en
BR112015015493A2 (en
Inventor
Havrileck Bertrand
Delhom Nathalie
Original Assignee
Virbac
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virbac filed Critical Virbac
Publication of BR112015015493A2 publication Critical patent/BR112015015493A2/en
Publication of BR112015015493A8 publication Critical patent/BR112015015493A8/en
Publication of BR112015015493B1 publication Critical patent/BR112015015493B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

resumo “composição farmacêutica que contém um derivado de n-fenilpirazol e de permetrina, uso para a preparação de um medicamento veterinário tópico” a presente invenção trata de uma composição farmacêutica veterinária tópica constituída de um n-fenilpirazol, de permetrina e de um inibidor de mudança de fase escolhido entre o etanol, o álcool benzílico e sua mistura; de seu uso na prevenção e/ou no tratamento das infestações des animais domésticos por parasitas externos.abstract "pharmaceutical composition containing a derivative of n-phenylpyrazole and permethrin, use for the preparation of a topical veterinary drug" the present invention deals with a topical veterinary pharmaceutical composition consisting of an n-phenylpyrazole, permethrin and a phase change chosen between ethanol, benzyl alcohol and their mixture; of its use in the prevention and/or treatment of infestations of domestic animals by external parasites.

BR112015015493-0A 2012-12-27 2013-12-20 VETERINARY PHARMACEUTICAL COMPOSITION AND USE OF A VETERINARY PHARMACEUTICAL COMPOSITION BR112015015493B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1262822A FR3000393B1 (en) 2012-12-27 2012-12-27 TOPICAL ASSOCIATION OF N-PHENYLPYRAZOLE AND PERMETHRIN
FR1262822 2012-12-27
PCT/IB2013/061218 WO2014102693A1 (en) 2012-12-27 2013-12-20 Pharmaceutical composition containing a derivative of n-phenylpyrazole and permethrin, and use for the production of a topical veterinary medicament

Publications (3)

Publication Number Publication Date
BR112015015493A2 BR112015015493A2 (en) 2017-07-11
BR112015015493A8 true BR112015015493A8 (en) 2019-10-22
BR112015015493B1 BR112015015493B1 (en) 2020-11-24

Family

ID=48224910

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015015493-0A BR112015015493B1 (en) 2012-12-27 2013-12-20 VETERINARY PHARMACEUTICAL COMPOSITION AND USE OF A VETERINARY PHARMACEUTICAL COMPOSITION

Country Status (5)

Country Link
EP (1) EP2938361A1 (en)
AU (1) AU2013368970A1 (en)
BR (1) BR112015015493B1 (en)
FR (1) FR3000393B1 (en)
WO (1) WO2014102693A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9392792B1 (en) * 2014-12-30 2016-07-19 Virbac Topical combination of fipronil, permethrin and pyriproxyfen

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8713768D0 (en) 1987-06-12 1987-07-15 May & Baker Ltd Compositions of matter
GB8816915D0 (en) 1988-07-15 1988-08-17 May & Baker Ltd New compositions of matter
FR2739255B1 (en) * 1995-09-29 1998-09-04 Rhone Merieux PEST CONTROL COMPOSITION FOR THE TREATMENT AND PROTECTION OF PETS
US6660768B2 (en) 2001-02-08 2003-12-09 Schering-Plough Animal Health Corporation Parasiticidal compositions and methods of use
DE102006061538A1 (en) 2006-12-27 2008-07-03 Bayer Healthcare Ag Agent for controlling parasites on animals comprises an N-phenylpyrazole, a pyrethroid, an aliphatic cyclic carbonate and an aliphatic polyether
US9433615B2 (en) 2007-09-06 2016-09-06 The Hartz Mountain Corporation Animal parasite-control method using insect growth regulators
AU2008365564B2 (en) * 2008-12-16 2015-08-27 Virbac Pharmaceutical composition containing an N-phenylpyrazole derivative, and use thereof for preparing a topical veterinary drug for flea control
CN102821606A (en) 2009-09-22 2012-12-12 军士宠物护理用品股份有限公司 Spot-on pesticide composition

Also Published As

Publication number Publication date
WO2014102693A1 (en) 2014-07-03
BR112015015493B1 (en) 2020-11-24
FR3000393B1 (en) 2015-01-16
BR112015015493A2 (en) 2017-07-11
EP2938361A1 (en) 2015-11-04
AU2013368970A1 (en) 2015-07-16
FR3000393A1 (en) 2014-07-04

Similar Documents

Publication Publication Date Title
BR112015014372A2 (en) autotaxin inhibitors
GT201000160A (en) AMINOBENZAMIDE DERIVATIVES AS USEFUL AGENTS FOR THE CONTROL OF PARASITES OF ANIMALS
BR112015011403A2 (en) use of akkermansia for the treatment of metabolic disorders
BR112015011036A2 (en) heterocyclic substituted 2-amino-quinazoline derivatives for the treatment of viral infections
BRPI0924460A2 (en) pharmaceutical composition for use in medical and veterinary ophthalmology
BR112015020302A2 (en) pyrazole derivative
BR112015016001A2 (en) compounds, pharmaceutical compositions and their uses and method for treating or preventing bacterial infection
BR112015016315A2 (en) fluoro- [1,3] oxazine as bace1 inhibitors
BR112014022214A2 (en) antibacterial phenolics
BR112014016808A8 (en) biguanide compositions and methods for treating metabolic disorders
BR112015007366A2 (en) acylaminopyrimidine derivatives for the treatment of viral infections and other diseases
BR112015019412A8 (en) bace1 inhibitors, their uses, and pharmaceutical composition
CL2008001820A1 (en) Aryl-isoxasol-imidazole derived compounds; preparation procedure; pharmaceutical composition containing them; and use in the preparation of useful drugs in the treatment of cognitive disorders and Alzheimer's-related diseases.
BR112013028895A2 (en) (thio) bicyclic carbonylamidines
PT103884A (en) PROLONGED RELEASE COMPOSITIONS AND METHODS FOR THEIR PREPARATION
BR112017022757A2 (en) pyrazole derivatives useful as inhibitors of 5-lipoxygenase activating protein (flap)
BR112015028876A2 (en) perhydroquinoxaline derivatives
BR112017021583A2 (en) Methods for treating inflammatory disorders
BR112016027383A8 (en) naphthyridinedione derivatives, their uses, pharmaceutical composition and combination
BR112015029073A8 (en) dispersed dyes, their use and production process, and process for dyeing and printing hydrophobic materials
BR112022009563A2 (en) PYROLOTRIAZINE COMPOUNDS ACTING AS A MNK INHIBITOR
BR112018068170A2 (en) (2s, 4r) -5- (5'-chloro-2'-fluoro- [1,1'-biphenyl] -4-yl) -2- (ethoxymethyl) -4- (3-hydroxy-isoxazol-5-acid) crystalline -carboxamido) -2-methylpentanoic and uses thereof
BR112015015493A8 (en) veterinary pharmaceutical composition and use of a veterinary pharmaceutical composition
UY36098A (en) COMPOSITE 1,1? -ADIPOYLBIS (PIRROLIDINE-2-CARBOXYLATE) OF (2R, 2? R) -BIS ((((((TETRAHIDRO-2H-PIRAN-4- IL) OXI) CARBONIL) OXI) METHYL), FOR TREATMENT OF SYSTEMIC AMYLOIDOSIS.
BR112015017381A2 (en) topical eye analgesic agents

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 20/12/2013, OBSERVADAS AS CONDICOES LEGAIS.